Advertisement
Screener

CULLINAN THERAPEUTICS, INC. (CGEM) Auditor

CULLINAN THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-10: Fiscal year end 2025-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, Massachusetts.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, Massachusetts.
  • 2024-03-14: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, Massachusetts.
  • 2023-03-09: Fiscal year end 2022-12-31; Auditor KPMG LLP; PCAOB firm ID 185; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-102025-12-31KPMG LLP185Boston, MassachusettsNo
2025-02-272024-12-31KPMG LLP185Boston, MassachusettsYes
2024-03-142023-12-31KPMG LLP185Boston, MassachusettsNo
2023-03-092022-12-31KPMG LLP185Boston, MassachusettsNo
2022-03-172021-12-31KPMG LLP185Boston, MassachusettsNo
2021-03-302020-12-31KPMG LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Replimune Group, Inc. (REPL)United States$1.186B-3.13
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10